Home > Insider Trading > Filing (0001567619-22-017725)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1668397	Medpace Holdings Inc.	MEDP	()	4

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1622058	J. August Troendle	C/O Medpace Holdings, Inc. 5375 Medpace Way Cincinnati OH 45227	Ceo	Yes	Yes	Yes	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2022-09-20	94,119	$155.14	6,331,474	No	4	P	Indirect	By Medpace Investors, LLC
Common Stock	Acquisiton	2022-09-21	94,119	$161.63	6,425,593	No	4	P	Indirect	By Medpace Investors, LLC

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Indirect	By Medpace Investors, LLC
No	4	P	Indirect	By Medpace Investors, LLC

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	806,643	Direct

Footnotes

The purchases reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by Medpace Investors, LLC ("MPI") on March 17, 2022, as amended on May 3, 2022 and August 15, 2022.
The reported price is a weighted average price. These shares were purchased in multiple transactions ranging from $151.72 to $157.02. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission upon request.
The Reporting Person is the sole manager and controlling unit holder of MPI and has sole voting and investment control with respect to the securities held by MPI. The Reporting Person may be deemed to indirectly beneficially own the securities of the Issuer held by MPI but disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein.
The reported price is a weighted average price. These shares were purchased in multiple transactions ranging from $157.83 to $163.71. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission upon request.